Personalized Immune Cell Treatment
NKCL Classic
Meet the blockchain structure of NKCL Classic, where biotechnology and blockchain technology are perfectly combined
NK cells play a major role in our immune system
Explore NKCL Classic Project
NKCL Bio Group announced on the 31st that it has obtained both CE certification and KC certification on the 2..
NKCL Bio Group Inc. won the grand prize in the NK cell therapy category at the 17th ‘Korea Health Industry Awa..
NKCL Bio Group announced that it had recently acquired a patent for a stimulant composition for rapid testing o..
NKCL Bio Group Inc. won the ‘2023 Customer Love Brand Grand Prize’ in the immune care platform category.|Grow..
Potential for Growth in the Domestic Cell Therapy Market through the Application of Negative Regulation The..
[ NKCL participates as an anchor company in the Chungbuk Advanced Regenerative Bio Global Innovation Special Zo..
NKCL Bio Group Inc. (Chairman: Shin Dong-hwa) won the Innovation Management Technology Award at the '10th 2023 ..
NKCL Bio Group Inc. Receives 'Minister of Science and Technology Award'NKCL Bio Group Inc. (led by ..
"Chairman Shin Dong-hwa: 'Leading Technology and Market in the Field of NK Cells to Enhance National Competitiv..
NKCL Bio Group, which has consistently contributed to the advancement of the bio industry in South Korea, inclu..
소중한 정보를 남겨주시면 상담을 위한 신속한 연락 드리겠습니다.
